Małgorzata A. Knapp

Dr. Małgorzata A. Knapp

Cardiology Department, Medical University of Białystok, Poland, 15-276 Białystok, 24A Sklodowskiej str.

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
Małgorzata A. KnappMałgorzata A. Knapp
Małgorzata A. Knapp
ALAnna Lisowska
Anna Lisowska
PZPiotr Zabielski
Piotr Zabielski
WMWłodzimierz Musiał
Włodzimierz Musiał
MBMarcin Baranowski
Marcin Baranowski

1 June 2010 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
PKPawel Knapp
Pawel Knapp
MBMarcin Baranowski
Marcin Baranowski
Małgorzata A. KnappMałgorzata A. Knapp
Małgorzata A. Knapp
PZPiotr Zabielski
Piotr Zabielski
ABAgnieszka Urszula Blachnio-Zabielska
Agnieszka Urszula Blachnio-Zabielska
JGJan Górski
Jan Górski

12 March 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAnna Klimiuk
Anna Klimiuk
Anna ZalewskaAnna Zalewska
Anna Zalewska
RSRobert Sawicki
Robert Sawicki
Małgorzata A. KnappMałgorzata A. Knapp
Małgorzata A. Knapp
Mateusz MaciejczykMateusz Maciejczyk
Mateusz Maciejczyk
The aim of the study was to evaluate the rate of reactive oxygen species (ROS) production, antioxidant barrier, and oxidative damage in non-stimulated (NWS) and stimulated (SWS) saliva as well as plasma/erythrocytes of 50 patients with chronic heart failure (HF) divided into the two subgroups: NYHA II (33 patients) and NYHA III (17 patients). The activity of superoxide dismutase and catalase was statistically increased in NWS of HF patients as compared to healthy controls. The free radical formation, total oxidant status, level of uric acid, advanced glycation end products (AGE), advanced oxidation protein products and malondialdehyde was significantly elevated in NWS, SWS, and plasma of NYHA III patients as compared to NYHA II and controls. We were the first to demonstrate that with the progression of HF, disturbances of enzymatic and non-enzymatic antioxidant defense, and oxidative damage to proteins and lipids occur at both central (plasma/erythrocytes) and local (saliva) levels. In the study group, we also observed a decrease in saliva secretion, total salivary protein and salivary amylase activity compared to age- and gender-matched control group, which indicates secretory dysfunction of salivary glands in patients with HF. Salivary AGE may be a potential biomarker in differential diagnosis of HF.

9 September 2012 in Basic Research in Cardiology
Verified
Journal Article
Open access
PDF file
Małgorzata A. KnappMałgorzata A. Knapp
Małgorzata A. Knapp
MŻMałgorzata Żendzian-Piotrowska
Małgorzata Żendzian-Piotrowska
ABAgnieszka Urszula Blachnio-Zabielska
Agnieszka Urszula Blachnio-Zabielska
PZPiotr Zabielski
Piotr Zabielski
KKKrzysztof Kurek
Krzysztof Kurek
JGJan Górski
Jan Górski
Three bioactive sphingolipids, namely sphingosine-1-phosphate (S1P), ceramide (CER) and sphingosine (SPH) were shown to be involved in ischemia/reperfusion injury of the heart. S1P is a powerful cardioprotectant, CER activates apoptosis and SPH in a low dose is cardioprotective whereas in a high dose is cardiotoxic. The aim of the present study was to examine effects of experimental myocardial infarction on the level of selected sphingolipids in plasma, erythrocytes and platelets in the rat. Myocardial infarction was produced in male Wistar rats by ligation of the left coronary artery. Blood was taken from the abdominal aorta at 1, 6 and 24 h after the ligation. Plasma, erythrocytes and platelets were isolated and S1P, dihydrosphingosine-1-phosphate (DHS1P), SPH, dihydrosphingosine (DHS) and CER were quantified by means of an Agilent 6460 triple quadrupole mass spectrometer using positive ion electrospray ionization source with multiple reaction monitoring. The infarction reduced the plasma level of S1P, DHS1P, SPH and DHS but increased the level of total CER. In erythrocytes, there was a sharp elevation in the level of SPH and DHS early after the infarction and a reduction after 24 h whereas the level of S1P, DHS1P and total CER gradually increased. In platelets, the level of each of the examined compounds profoundly decreased 1 and 6 h after the infarction and partially normalized in 24 h. The results obtained clearly show that experimental heart infarction in rats produces deep changes in metabolism of sphingolipids in the plasma, platelets and erythrocytes.


1 January 2010 in Journal of Lipid Research
Verified
Journal Article
Open access
MBMarcin Baranowski
Marcin Baranowski
ABAgnieszka Urszula Blachnio-Zabielska
Agnieszka Urszula Blachnio-Zabielska
THTomasz Adam Hirnle
Tomasz Adam Hirnle
DHDorota Harasiuk
Dorota Harasiuk
KMKrzysztof Matlak
Krzysztof Matlak
JGJan Górski
Jan Górski
Data from animal experiments strongly suggest that ceramide is an important mediator of lipotoxicity in the heart and that accumulation of ceramide contributes to cardiomyocyte apoptosis associated with type 2 diabetes and obesity. However, it remains unknown whether a similar relationship is present also in the human heart. Therefore, we aimed to examine whether myocardial apoptosis in obese and type 2 diabetic patients is associated with elevated ceramide level. The study included 11 lean and 26 overweight or moderately obese subjects without (n = 11, OWT) or with (n = 15, T2D-OWT) a history of type 2 diabetes. Samples of the right atrial appendage were obtained from patients at the time of coronary bypass surgery. Compared with lean subjects, the extent of DNA fragmentation (a marker of apoptosis) was significantly higher in the myocardium of OWT patients and increased further in T2D-OWT subjects. However, the content of ceramide and sphingoid bases remained stable. Interestingly, the mRNA level of enzymes involved in synthesis and degradation of ceramide including serine palmitoyltransferase, sphingosine kinase 1, neutral sphingomyelinase, and ceramidases was markedly higher in the myocardium of OWT and T2D-OWT patients compared with lean subjects. Our results indicate that in the human heart, or at least in the atrium, ceramide is not a major factor in cardiomyocyte apoptosis associated with obesity and type 2 diabetes.